GLENN LEVINE to Time Factors
This is a "connection" page, showing publications GLENN LEVINE has written about Time Factors.
Connection Strength
0.167
-
It Is Time to End the Dualistic Short Versus Long Duration of Dual Antiplatelet Therapy Debates. Circulation. 2017 06 20; 135(25):2451-2453.
Score: 0.066
-
2016 ACC/AHA Guideline Focused?Update on Duration of Dual?Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task?Force?on?Clinical Practice Guidelines. J Am Coll Cardiol. 2016 09 06; 68(10):1082-115.
Score: 0.060
-
Do We Need Potent Intravenous Antiplatelet Inhibition at the Time of Reperfusion During ST-Segment Elevation Myocardial Infarction? J Cardiovasc Pharmacol Ther. 2019 05; 24(3):215-224.
Score: 0.018
-
Impact of diabetes mellitus on percutaneous revascularization (CAVEAT-I). CAVEAT-I Investigators. Coronary Angioplasty Versus Excisional Atherectomy Trial. Am J Cardiol. 1997 Mar 15; 79(6):748-55.
Score: 0.016
-
A novel point-of-care enoxaparin monitor for use during percutaneous coronary intervention. Results of the Evaluating Enoxaparin Clotting Times (ELECT) Study. J Am Coll Cardiol. 2003 Sep 17; 42(6):1132-9.
Score: 0.006